Skip Navigation

American Journal of Epidemiology 2005 161(4):307-320; doi:10.1093/aje/kwi055
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gennari, L.
Right arrow Articles by Nuti, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gennari, L.
Right arrow Articles by Nuti, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2005 by the Johns Hopkins Bloomberg School of Public Health

HUMAN GENOME EPIDEMIOLOGY (HuGE) REVIEW

Estrogen Receptor Gene Polymorphisms and the Genetics of Osteoporosis: A HuGE Review

L. Gennari1 , D. Merlotti1, V. De Paola1, A. Calabrò1, L. Becherini2, G. Martini1 and R. Nuti1

1 Department of Internal Medicine, Endocrine-Metabolic Sciences and Biochemistry, Faculty of Medicine, University of Siena, Siena, Italy.
2 Department of Clinical Physiopathology, Faculty of Medicine, University of Florence, Florence, Italy.

Osteoporosis (OMIM166710) is a common skeletal disorder characterized by low bone mass and microarchitectural deterioration of bone tissue with increased susceptibility to fracture. Osteoporosis has a complex etiology and is considered a multifactorial polygenic disease in which genetic determinants are modulated by hormonal, environmental, and nutritional factors. Estrogens are known to play an important role in regulating bone homeostasis and preventing postmenopausal bone loss. They act through binding to two different estrogen receptors (ERs), ER{alpha} (OMIM133430) and ERß (OMIM601663), which are members of the nuclear receptor superfamily of ligand-activated transcription factors. Different polymorphisms have been described in both the ER {alpha} and ER ß genes. Although a large number of association studies have been performed, the individual contribution of these polymorphisms to the pathogenesis of osteoporosis remains to be universally confirmed. Moreover, an important aim in future work will be to define their functional molecular consequences and their interaction with the environment in the causation of the osteoporotic phenotype. A further promising application of these polymorphisms comes from their pharmacogenomic implications, with the possibility of providing better guidance for therapeutic regimens, such as estrogen replacement therapy and selective ER modulators. At the moment, no recommendations for population-based screening can be made.

epidemiology; estrogen receptor alpha; estrogen receptor beta; genetics; genome, human; osteoporosis; polymorphism, genetic


Abbreviations: BMD, bone mineral density; ER, estrogen receptor; PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism; VDR, vitamin D receptor; VNTR, variable number of tandem repeats.


Correspondence to Dr. Luigi Gennari, Department of Internal Medicine, Endocrine-Metabolic Sciences and Biochemistry, University of Siena, Viale Bracci, 53100 Siena, Italy (e-mail: gennari{at}unisi.it).


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
V. M. Miller and S. P. Duckles
Vascular Actions of Estrogens: Functional Implications
Pharmacol. Rev., June 1, 2008; 60(2): 210 - 241.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
D. A. Rider, C. Dombrowski, A. A. Sawyer, G. H. B. Ng, D. Leong, D. W. Hutmacher, V. Nurcombe, and S. M. Cool
Autocrine Fibroblast Growth Factor 2 Increases the Multipotentiality of Human Adipose-Derived Mesenchymal Stem Cells
Stem Cells, June 1, 2008; 26(6): 1598 - 1608.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
U. Styrkarsdottir, B. V. Halldorsson, S. Gretarsdottir, D. F. Gudbjartsson, G. B. Walters, T. Ingvarsson, T. Jonsdottir, J. Saemundsdottir, J. R. Center, T. V. Nguyen, et al.
Multiple Genetic Loci for Bone Mineral Density and Fractures
N. Engl. J. Med., May 29, 2008; 358(22): 2355 - 2365.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. S. Legro, H. X. Barnhart, W. D. Schlaff, B. R. Carr, M. P. Diamond, S. A. Carson, M. P. Steinkampf, C. Coutifaris, P. G. McGovern, N. A. Cataldo, et al.
Ovulatory Response to Treatment of Polycystic Ovary Syndrome Is Associated with a Polymorphism in the STK11 Gene
J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 792 - 800.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
S. de Voogd, R. C. W. Wolfs, N. M. Jansonius, A. G. Uitterlinden, H. A. P. Pols, A. Hofman, and P. T. V. M. de Jong
Estrogen Receptors Alpha and Beta and the Risk of Open-angle Glaucoma: The Rotterdam Study
Arch Ophthalmol, January 1, 2008; 126(1): 110 - 114.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
R.M. Corbo, L. Ulizzi, L. Piombo, C. Martinez-Labarga, G.F. De Stefano, and R. Scacchi
Estrogen receptor alpha polymorphisms and fertility in populations with different reproductive patterns
Mol. Hum. Reprod., August 1, 2007; 13(8): 537 - 540.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. S. Boekhoorn, J. R. Vingerling, A. G. Uitterlinden, J. B. J. Van Meurs, C. M. van Duijn, H. A. P. Pols, A. Hofman, and P. T. V. M. de Jong
Estrogen Receptor {alpha} Gene Polymorphisms Associated with Incident Aging Macula Disorder
Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1012 - 1017.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. D. Kjaergaard, C. Ellervik, A. Tybjaerg-Hansen, C. K. Axelsson, M.-L. M. Gronholdt, P. Grande, G. B. Jensen, and B. G. Nordestgaard
Estrogen Receptor {alpha} Polymorphism and Risk of Cardiovascular Disease, Cancer, and Hip Fracture: Cross-Sectional, Cohort, and Case-Control Studies and a Meta-Analysis
Circulation, February 20, 2007; 115(7): 861 - 871.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. A. Carey, J. W. Card, J. A. Bradbury, M. P. Moorman, N. Haykal-Coates, S. H. Gavett, J. P. Graves, V. R. Walker, G. P. Flake, J. W. Voltz, et al.
Spontaneous Airway Hyperresponsiveness in Estrogen Receptor-{alpha}-deficient Mice
Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 126 - 135.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
J. A Riancho, M. T Zarrabeitia, C. Valero, C. Sanudo, V. Mijares, and J. Gonzalez-Macias
A gene-to-gene interaction between aromatase and estrogen receptors influences bone mineral density.
Eur. J. Endocrinol., July 1, 2006; 155(1): 53 - 59.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. Guarducci, F. Nuti, L. Becherini, M. Rotondi, G. Balercia, G. Forti, and C. Krausz
Estrogen receptor {alpha} promoter polymorphism: stronger estrogen action is coupled with lower sperm count
Hum. Reprod., April 1, 2006; 21(4): 994 - 1001.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. L. Slattery, C. Sweeney, M. Murtaugh, K. N. Ma, R. K. Wolff, J. D. Potter, B. J. Caan, and W. Samowitz
Associations between ER{alpha}, ER{beta}, and AR Genotypes and Colon and Rectal Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2936 - 2942.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.